In contrast, AML in elderly patients is more likely to be resistant to treatment, due to the overexpression of MDR1 and MRP1, two genes involved in the expulsion of chemotherapeutic agents [32,37] as observed in HL-60 and K562 cell lines resistant to cytarabine [38]. Here, ABCB1 is linked to acute myeloid leukemia.